Track topics on Twitter Track topics that are important to you
Now in its 26th year, COLLOQUY is a leading publishing, education and research practice, bringing together loyalty practitioners from around the world. A pioneer in the industry, COLLOQUY is the first publication dedicated expressly to the art and science of loyalty marketing and has since become the go-to resource for loyalty intelligence. Today COLLOQUY engages and educates loyalty marketers with its magazine, e-newsletter and timely and comprehensive loyalty-marketing website, colloquy.com. COLLOQUY delivers industry-leading loyalty benchmarking reports and educational workshops, webinars and speeches. Advertising, sponsorship and publishing opportunities are available via the COLLOQUY Network, a global partnership of loyalty service providers. COLLOQUY is an independently operated division of LoyaltyOne. To learn more, visit colloquy.com.
Now in its 26th year, COLLOQUY is a leading publishing, education and research practice, bringing together loyalty practitioners from around the world. A pioneer in the industry, ...
We have published hundreds of COLLOQUY news stories on BioPortfolio along with dozens of COLLOQUY Clinical Trials and PubMed Articles about COLLOQUY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of COLLOQUY Companies in our database. You can also find out about relevant COLLOQUY Drugs and Medications on this site too.
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...